Posted by AGORACOM-JC
at 4:24 PM on Thursday, December 30th, 2021
FOBI AI is a global leader in digital wallet pass technology that delivers real-time data analytics and engagement through artificial intelligence to drive customer activation and engagement in stores, stadiums, arenas, hotels and other large venues around the world.
More than just lip service, FOBI AI is firing on all cylinders. Here are just some of the highlights from December:
Posted by AGORACOM-JC
at 10:18 AM on Saturday, December 25th, 2021
The Roundup
A weekly summary of Novamind news and media
Dr. Steve Thayer with an important reminder that, for some, the holidays can be a difficult time of year for many reasons. He shares tips to care for our mental health and wellbeing over the holidays.
We are pleased to announce the signing of a definitive agreement to acquire Arizona-based Foundations for Change, a mental health practice specialized in ketamine-assisted psychotherapy, from its sole stockholder, Jeff Edelman. The transaction is subject to regulatory approvals and is expected to close in January 2022.
Opened in 2017 by Jeff Edelman, Foundations currently operates one outpatient mental health clinic in Peoria, Arizona with an annual revenue run rate in excess of US$800,000 and owns a second, larger location in Phoenix that is scheduled to open in early 2022. Foundations will temporarily operate as “Foundations for Change by Novamind” until the Company completes its recently announced rebrand. Mr. Edelman will continue in a leadership capacity as Medical Director for both clinics. Mr. Edelman is double board-certified Family Psychiatric-Mental Health Nurse Practitioner and a Child and Adolescent Psychiatric-Mental Health Clinical Nurse Specialist. As a former military combat veteran, who served in the US Army 55th Medical Co. Combat Stress Control unit, Mr. Edelman has special expertise in treating military veterans and first responders who struggle with stress and trauma.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison catch up after their recent trip to the “Horizons: Perspectives on Psychedelics” conference in New York. Stay tuned next week for our last episode of 2021 and a special PTF podcast contest and giveaway.
NBC News reports on a first-of-its kind clinical trial at the University of Washington School of Medicine to treat 30 medical professionals experiencing depression with a dose of synthetic psilocybin combined with psychotherapy. Some say that even five years ago, this would have been considered taboo. “That medical researchers are turning toward psilocybin to treat colleagues is representative of a growing curiosity and acceptance of the drug among those in the medical establishment.” We’re seeing that openness, too, through our Frontline KAP clinical pilot to help healthcare workers heal.
Posted by AGORACOM-JC
at 5:20 PM on Tuesday, December 21st, 2021
We all remember the crash of “blockchain” stocks a couple of years back, which was actually a crash of blockchain pretenders who used the term to build stock promotions, as opposed to building actual blockchains.
Like the dot-com crash of 2000, which bankrupted “dot-com” companies but gave birth to the likes of Google, Amazon, Linkedin because they built actual utility and value, the same could be expected of the blockchain crash and its’ resurgence.
But Blockchain Foundry is only just getting started. The Company is building a WEB3 ecosystem on top of its powerful Sycoin blockchain which is the 2nd most secure blockchain in the world next to Bitcoin. That isn’t a typo and Web3 coin investors believe it given the fact it has traded over $13,000,000 in volume over the last 24 hours … and close to $25,000,000 in the 24 hours before that!
What do they know that small cap investors don’t know? What to Web3 investors know that isn’t being reflected in the $BCFN stock price? The short answer is .. A Lot … but luckily we were able to tear away CEO Dan Wasyluk from his coding marathons to explain exactly what we are missing by going through the Company’s power point presentation.
If you’re a small cap investor looking for exposure to the Web3 world of blockchain, coins, tokens, NFTs and more then this $BCFN presentation is a must-watch.
Posted by AGORACOM-JC
at 4:38 PM on Friday, December 17th, 2021
Valeo Pharma is already a successful, revenue-generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
Q3 Highlights:
Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter.
Record gross margin of $2.2 million , up 1602% over Q3 2020 and 204% over prior quarter.
Record 9 months revenues at $10.2 million , up 94%
Public reimbursement now includes Alberta , Quebec and Nova Scotia , representing approximately 37% of the Canadian population.
More than 90% private insurance coverage across Canada
Frederic Fasano, Valeo’s President and Chief Operating Officer commented,
“We are pleased to be reporting today the addition of Quebec and Nova Scotia to join Alberta on the list of provincial public coverage secured for both asthma medications. Public Reimbursement access makes a meaningful impact for asthma patients left with no coverage so far, and also simplify health care providers procedures to provide access of both medications to their patients. Enerzair and Atectura are innovative asthma therapies that are helping make asthma control a more attainable goal for Canadians asthma patients”.
Posted by AGORACOM-JC
at 9:09 AM on Thursday, December 16th, 2021
An emerging esports and iGaming company that is creating an Esports adventure like no other …. Create the world’s foremost esports and iGaming ecosystem.
The global online gambling market could potentially hit $1 TRILLION by the end of this decade. The obvious reasons include the following:
Exponential growth in the number of people online. Yet only 59% of the world means more to come.
Fast growth in the number of countries and jurisdictions legalizing gambling to collect tax revenue.
Esports was already the fastest growing sub-sector of digital entertainment, and Covid 19 has only accelerated this trend.
Biggest brands/tournament prizes / online audiences in the world … 500M +
The International Olympic Committee has recognized esports as a sport, and it will be a medal event at the 2022 Asian Games
Despite the vast amount of viewers, esports is still dramatically under-monetized relative to traditional sports. ITM believes wagering will play a major role in helping monetize this ever-evolving platform.
Intema has had an active first half of December evident by the following:
Goal of expanding Intema’s esports and iGaming operations in the U.S.
letter of intent with Wild Rose Entertainment to operate a LOOT.BET sports wagering skin in the state of Iowa
Betting handle in Iowa estimated at more than US$1 billion in 2021, having reached $287 million in November 2021 (Source: gambling.com, December 10, 2021)
Laurent Benezra, President and CEO of Intema,
“We are thrilled to welcome Bill to the Intema team and are impressed with what he has managed to accomplish in a very short period of time. The LOI with Wild Rose is just the beginning of what the LOOT.BET platform could bring to Intema once its acquisition is finalized.”
“The grant of the Isle of Man gambling license is major news for Intema and will have a significant positive impact on our future activities. In particular, it allows us to comply with one of the TSX Venture Exchange’s main conditions for closing the acquisition of Livestream Gaming Inc. (“ Livestream ”), with its LOOT.BET online gaming platform. It will also enable us to conduct our iGaming activities through one of the world’s most prestigious gaming jurisdictions and, once we acquire our LOOT.BET platform, to white-label it to regulated gaming markets on a global scale. Finally, it gives LOOT.BET the same level of credibility as other online gambling platforms, throughout the gaming community and among our peers.”
Sit back, relax and watch this powerful interview.
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza
We are pleased to announce the opening of a new clinic located in downtown Salt Lake City (SLC). In addition to Novamind’s suite of mental health treatments, the SLC Clinic specializes in integrative behavioural health and services for adults with substance use disorders (SUD) led by incoming Medical Director, Dr. Amy de la Garza.
The SLC Clinic’s outpatient SUD services provide an alternative to residential treatment programs and work to address the highly complex public health crisis that is worsening alongside challenges related to access. In 2020 alone, 93,000 Americans died of a drug overdose-an increase of 30 per cent from the previous year, according to the Centers for Disease Control and Prevention.
Dr. Reid Robison, Novamind’s Chief Medical Officer, commented: “Social isolation and despair related to the COVID-19 pandemic have further fueled a significant increase in substance use disorders and related deaths. Dr. de la Garza’s expertise in addiction medicine and behavioural health is a vital addition to our team as we continue to expand Novamind’s clinic footprint to address unmet need and broaden our innovative, evidence-based treatments.”
Dr. de la Garza is a board-certified family practice physician with 10 years of experience providing specialized care for patients with behavioral health and SUD diagnoses. She earned her Doctorate in Medicine from the University of Colorado before completing a Family Medicine Residency at the Utah Healthcare Institute. She also completed an Addiction Medicine Fellowship at the University of Utah and is an Institute for Functional Medicine Certified Practitioner. In 2017, Dr. de la Garza opened the first community-based, co-located primary care and behavioral health practice in Salt Lake City, Utah.
“I am thrilled to join Novamind and look forward to establishing an innovative outpatient substance use disorder program that brings together addiction and integrative medicine and treats the whole person,” said Dr. de la Garza, who is also trained in integrative modalities and lifestyle medicine, including nutrition, movement, sleep, stress management and social connection.
Novamind will collect clinical data on the efficacy of the integrative treatment approach for SUD and host upcoming studies for conditions like opioid use disorder. Additionally, the SLC Clinic will pilot an innovative and cost-effective group medical visit model that has been shown to reduce anxiety and depression, as well as improve outcomes in chronic conditions like cardiovascular disease and diabetes.
The SLC Clinic is located at 807 E South Temple, Suite 101, Salt Lake City, Utah.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore anxiety. They discuss the following topics and much more: • What is an anxiety disorder? • Anxiety management skills • The role of medicines in treating anxiety
Utah Business covers Dr. Reid Robison and the success of ketamine-assisted psychotherapy in our clinics. “While it’s still early and much more testing is to be done, Robison describes what’s happening in mental health care as a ‘psychedelic renaissance’.”
Dr. Reid Robison, Matt Johnson and Robin Carhart-Harris discuss The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions.
Chief Medical Officer Dr. Reid Robison’s keynote presentation at the Mind Medicine Australia International Summit on Psychedelic Therapies for Mental Illness.
“While the U.S. has been battling Covid-19 it’s gotten lost in the shuffle that the nation had record numbers of drug overdose-related deaths in 2020; approximately 93,000. In addition, from May 2020 through April 2021, the figure rises to 100,000.” We need better treatment options for people with substance use disorders (SUD). It’s the driving force behind why incoming Novamind Medical Director Dr. Amy de la Garza will lead SUD programming at our new Salt Lake City clinic.
We are currently in a mental health crisis. Depression, anxiety and symptoms of PTSD have run rampant over the last two years, accelerated by the COVID-19 pandemic and its far-reaching effects. The need for new and effective mental health treatments has never been clearer. We have seen the efficacy of ketamine-assisted psychotherapy firsthand. And we are eager to continue psychedelic research. If you’d like to stay up to date on upcoming studies hosted by Novamind, visit us here and get in touch. “So what else does the future hold for psychedelics? For one thing, taking psychedelics could one day be the same as taking an everyday pill prescribed by your doctor.”
Posted by AGORACOM-JC
at 5:48 PM on Thursday, December 9th, 2021
Kidoz (KIDZ: TSXV) owns the biggest mobile advertising platform for kids and families. How big? There are almost 4,000 apps around the world using Kidoz, reaching over 300 MILLION kids. The company works with top brands, including Disney, McDonald’s, Hasbro, and Lego, and is a trusted partner of Apple and Google.
Total Revenue of $2,814,642 – growth of 47% compared to Q3 2020 Total Revenue of $1,919,973 and growth of 29% from revenue of $2,177,505 for the second quarter of 2021.
Gross Profit of $1,226,534 – growth of 34% compared to Q3 2020 Gross Profit of $914,657 and growth of 20% from Gross Profit of $1,024,333 for the second quarter of 2021.
Adjusted EBITDA of $265,984 compared to an adjusted EBITDA of $16,484 for Q2 2021.
We sat down with Kidoz Inc. Co-CEOs Jason Williams & Eldad Ben Tora to discuss their recently announced Programmatic Solution “Kidoz Connect”.
This new product release is a unique programmatic solution providing ‘review & monetize’ technology to enable open market ad sourcing at scale. Kidoz Connect enables any brand, agency or DSP to programmatically reach the Kidoz unique inventory of over 300 million users accessible in a fully COPPA/GDPR compliant manner, through a single point of integration.
This new technology could increase impressions sold by 3-5X.
Co-CEO Eldad Ben Tora commented,
“Kidoz Connect is currently live with select launch partners and we are actively developing and integrating a number of new sources that will together create the pipeline of programmatic ad campaigns available to Kidoz’s app publisher network. As Kidoz advances its multiple product offerings, new opportunities arise in the bountiful mobile advertising ecosystem that is projected by eMarketer to exceed over US$400 billion by 2023 (eMarketer). Kidoz is perfectly positioned with powerful technology in a booming market and management anticipates a record Q4 and 2022 ahead.”
Now sit back, relax and watch this powerful interview with Co-CEOs of Kidoz Inc.
Posted by AGORACOM-JC
at 5:45 PM on Thursday, December 9th, 2021
HypeX.gg recently acquired by Intema Solutions (ITM: TSXV) (ITMZF: OTC) has two divisions;
Retail
HypeX.gg is an Esports tournament and social platform.
Commercial
HypeX is a next-gen advertising platform specializing in endemic & non-endemic advertising opportunities.
HypeX has refined Esports demand into three major categories of individuals
Athletes,
Audience members and
Content creators.
By designing functionality & incentive to appeal to these three categories, HypeX creates seamless advertising opportunities for retail brands, organizations and companies.
HypeX is able to elicit specific consumer behaviours on behalf of the brand, offering a significantly greater ROI on their advertising budget.
HypeX has proven to be the home of Free-to-Enter tournaments with $100,000 + in prizes already paid out. In addition, the company boasts 50,000+ Users and has 20+ brand partnerships.
Posted by AGORACOM-JC
at 5:52 PM on Wednesday, December 8th, 2021
FOBI AI is a global leader in digital wallet pass technology that delivers real-time data analytics and engagement through artificial intelligence to drive customer activation and engagement in stores, stadiums, arenas, hotels and other large venues around the world.
More than just lip service, these are just a sample of the major milestones reached by $FOBI as of the end of November:
293% Increase In First Quarter Revenue
Signed Agreement With Caddle, Canada’s Largest Mobile-First Insights Marketplace App To Target And Engage CPG Brands and Grocery Retailers
Signed Deal to Provide Digital Vaccination and Testing Verification Solution for Sammy Hagar’s Sold Out Shows at The STRAT Hotel, Casino & SkyPod in Las Vegas
Signed CheckVax(TM) Deal With the University of Nevada, Las Vegas for Men’s and Women’s NCAA Basketball Games
By joining Amazon Business, Fobi immediately reaches over 5 million business customers in nine countries: a network that Fobi is very proud to now be included in. Fobi will now generate additional revenue through hardware, products and services sold on Amazon Business.
Rob Anson, Fobi CEO stated : “Acquiring Passworks will not only enable us to further accelerate our business strategy as we consolidate the wallet pass industry, but it will also provide us with direct and immediate access to very valuable customers, with additional operational capacity and provide further immediate revenue. This strategic acquisition of Passworks represents another key step for us in terms of achieving our goal of becoming a global mobile Wallet pass leader.”
Sit back, relax and watch this powerful interview with CEO Rob Anson.
Posted by AGORACOM-JC
at 5:48 PM on Wednesday, December 8th, 2021
HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high-value specialty silicon products needed for the coming RER along with 2 world-renowned technology partners.
high purity silicon metal
spherical silicon nanopowders and nanowires
porous silicon (Si) wafers and porous silicon (Si) powders
HPQ NANO Receives First Order for Spherical Nano Silicon Material from Major Automobile Manufacturer
NDA with at least 2 battery players
Pyrogenesis Canada (a global leader in plasma torch technologies) = 2 reactors
PUREVAP Quartz Reduction Reactors (QRR) to be Commissioned in Q4 2021
an innovative process (patent pending), which will permit the one-step transformation of quartz (SiO 2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint
PUREVAP TM Nano Silicon Reactor (NSiR ) Through its 100% owned subsidiary, HPQ NANO Silicon Powders Inc., a new proprietary process that can use different purities of silicon (Si) as feedstock, to make a wide range of nano/micro spherical powders of different sizes and nanowires.
EBH 2 first successfully tested prototype model has a clean energy production capacity starting at 1 Megawatt of power that can be produced over 7 days from 2 litres of water; sufficient energy to power a typical three bedroom suburban house.
The tests confirmed that the EBH 2 Green Hydrogen Reactors (EBH 2 GHR) uses low voltage 1 to power electrolysers that generate a H 2 + O 2 gas mixture fuels that can be used to power a generator or any kind of fuel system to produce electricity.
HPQ CEO Bernard Tourillon commented: “Corporations and Governments worldwide strongly believe that Hydrogen can play a significant part in decarbonising our economies, and they are willing to invest billions of dollars to help develop green hydrogen production. EBH2 Systems SA, with their proprietary low-cost electrolyser technology, present HPQ with one of these game changing synergetic opportunities that we simply could not overlook,” Mr. Tourillon, further stated: “We are getting even closer to the point where EBH 2 technology will be validated and when that occurs HPQ will be very well positioned to enter the hydrogen market with a system that can efficiently produce green hydrogen, on demand, which we believe will complement our green silicon materials initiatives needed to meet the demand of the up and coming renewable energy revolution.”
Sit back and watch this power interview with HPQ CEO Bernard Tourillon.
